back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-16 15:45 Tx date 2026-03-13 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-74,111.95
-1,342 vol $55.23 each |
7,301 | |
| Filed 2026-03-16 15:43 Tx date 2026-03-12 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,750 vol |
8,643 | |
| Filed 2026-03-16 15:42 Tx date 2026-03-12 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,750 vol |
26,250 | |
| Filed 2026-03-13 15:23 Tx date 2026-03-10 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-156,701.556
-2,607 vol $60.11 each |
4,893 | |
| Filed 2026-03-13 15:17 Tx date 2026-03-09 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-7,500 vol |
0 | |
| Filed 2026-03-13 15:15 Tx date 2026-03-09 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+7,500 vol |
7,500 | |
| Filed 2026-03-13 15:13 Tx date 2022-11-07 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-13 15:12 Tx date 2026-03-09 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+7,500 vol |
7,500 | |
| Filed 2026-03-13 15:05 Tx date 2022-11-07 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-01-12 18:07 Tx date 2026-01-09 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+15,000 vol |
30,000 | |
| Filed 2026-01-12 18:06 Tx date 2026-01-09 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+80,000 vol |
340,000 | |
| Filed 2025-06-10 13:45 Tx date 2025-03-12 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+15,000 vol |
15,000 | |
| Filed 2025-06-10 13:43 Tx date 2022-11-07 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-14 14:44 Tx date 2025-03-12 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
||
| Filed 2025-03-14 14:44 Tx date 2025-03-12 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
275,000 | |
| Filed 2025-03-14 14:42 Tx date 2025-03-12 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+80,000 vol |
260,000 | |
| Filed 2023-03-14 17:16 Tx date 2023-03-10 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+45,000 vol |
180,000 | |
| Filed 2022-11-09 17:19 Tx date 2022-11-07 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+135,000 vol |
135,000 | |
| Filed 2022-11-09 17:16 Tx date 2022-11-07 |
$XENE
Xenon Pharmaceuticals Inc. |
DiFabio, Andrea
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|